Roydhouse, JK and Menapace, LA and Xia, H and Song, P and Berman, TJ and Agarwal, R and Suzman, DL and Wright, K and Beaver, JA and Kluetz, PG, Concomitant botanical medicine use among patients participating in commercial prostate cancer trials, Complementary Therapies in Medicine, 54 pp. 1-8. ISSN 0965-2299 (2020) [Refereed Article]
© 2020 Elsevier Ltd. All rights reserved.
Design: Retrospective study.
Setting: Regulatory repository of commercial clinical trial data.
Interventions: Anti-cancer therapy.
Main outcome measures: Botanical and medication use data were pooled across six international commercial randomized trials for metastatic prostate cancer with detailed information on medication and indications. Botanical products were considered to have potential for drug interaction if they led to a change in drug exposure in human trials. Potential for interaction was ascertained by PubMed review. Descriptive statistics were used for analysis.
Results: Of 7,318 enrolled patients, 700 (10%) reported botanical use at any time and 653 (9%) reported use of botanical products while on trial. Nearly half of botanical product types were not classified by plant (43%). The highest proportion of botanical use was among patients in Asian countries (32%), followed by patients in North America (13%). Eighty-six different types of botanical products were used; of these, nineteen had a patient-reported anti-cancer indication.
Conclusions: Botanical medicine use among patients with prostate cancer in commercial trials is moderate, although it varies by region. Practitioners should be aware of the use of botanical interventions in a clinical trial context.
|Item Type:||Refereed Article|
|Keywords:||prostate cancer, clinical trial, herbal, concomitant|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Oncology and carcinogenesis|
|Research Field:||Oncology and carcinogenesis not elsewhere classified|
|Objective Group:||Clinical health|
|Objective Field:||Clinical health not elsewhere classified|
|UTAS Author:||Roydhouse, JK (Dr Jessica Roydhouse)|
|Deposited By:||Menzies Institute for Medical Research|
Repository Staff Only: item control page